Chloride channel-targeted therapy for secretory diarrheas

Walker, 2013, Global burden of childhood pneumonia and diarrhoea, Lancet, 381, 1405, 10.1016/S0140-6736(13)60222-6 Moore, 2010, Prolonged episodes of acute diarrhea reduce growth and increase risk of persistent diarrhea in children, Gastroenterology, 139, 1156, 10.1053/j.gastro.2010.05.076 Payne, 2013, Norovirus and medically attended gastroenteritis in U.S. children, N Engl J Med, 368, 1121, 10.1056/NEJMsa1206589 Munos, 2010, The effect of oral rehydration solution and recommended home fluids on diarrhoea mortality, Int J Epidemiol, 39, i75, 10.1093/ije/dyq025 MacArthur, 2012, Etiology and pharmacologic management of noninfectious diarrhea in HIV-infected individuals in the highly active antiretroviral therapy era, Clin Infect Dis, 55, 860, 10.1093/cid/cis544 Lin, 2011, d-Glucose acts via sodium/glucose cotransporter 1 to increase NHE3 in mouse jejunal brush border by a Na+/H+ exchange regulatory factor 2-dependent process, Gastroenterology, 140, 560, 10.1053/j.gastro.2010.10.042 Walker, 2009, Role of down-regulated in adenoma anion exchanger in HCO3− secretion across murine duodenum, Gastroenterology, 136, 893, 10.1053/j.gastro.2008.11.016 Gawenis, 2003, cAMP inhibition of murine intestinal Na/H exchange requires CFTR-mediated cell shrinkage of villus epithelium, Gastroenterology, 125, 1148, 10.1016/S0016-5085(03)01212-5 Murtazina, 2011, NHERF2 is necessary for basal activity, second messenger inhibition, and LPA stimulation of NHE3 in mouse distal ileum, Am J Physiol Cell Physiol, 301, C126, 10.1152/ajpcell.00311.2010 Teramae, 2010, The cellular expression of SMCT2 and its comparison with other transporters for monocarboxylates in the mouse digestive tract, Biomed Res, 31, 239, 10.2220/biomedres.31.239 Fritsch, 2002, Distribution of ClC-2 chloride channel in rat and human epithelial tissues, Am J Physiol Cell Physiol, 282, C805, 10.1152/ajpcell.00291.2001 Yu, 2010, Bestrophin-2 mediates bicarbonate transport by goblet cells in mouse colon, J Clin Invest, 120, 1722, 10.1172/JCI41129 Field, 1972, Effect of cholera enterotoxin on ion transport across isolated ileal mucosa, J Clin Invest, 51, 796, 10.1172/JCI106874 Rao, 1980, Mode of action of heat-stable Escherichia coli enterotoxin. Tissue and subcellular specificities and role of cyclic GMP, Biochim Biophys Acta, 632, 35, 10.1016/0304-4165(80)90247-0 Ball, 1996, Age-dependent diarrhea induced by a rotaviral nonstructural glycoprotein, Science, 272, 101, 10.1126/science.272.5258.101 Morris, 1999, NSP4 elicits age-dependent diarrhea and Ca2+ mediated I− influx into intestinal crypts of CF mice, Am J Physiol, 277, G431 Hoque, 2010, Epac1 mediates protein kinase A-independent mechanism of forskolin-activated intestinal chloride secretion, J Gen Physiol, 135, 43, 10.1085/jgp.200910339 Namkung, 2010, CFTR-adenylyl cyclase I association responsible for UTP activation of CFTR in well-differentiated primary human bronchial cell cultures, Mol Biol Cell, 21, 2639, 10.1091/mbc.E09-12-1004 Tradtrantip, 2009, Thiophenecarboxylate suppressor of cyclic nucleotides discovered in a small-molecule screen blocks toxin-induced intestinal fluid secretion, Mol Pharmacol, 75, 134, 10.1124/mol.108.050567 Li, 2005, Lysophosphatidic acid inhibits cholera toxin-induced secretory diarrhea through CFTR-dependent protein interactions, J Exp Med, 202, 975, 10.1084/jem.20050421 Ren, 2013, MAST205 competes with cystic fibrosis transmembrane conductance regulator (CFTR)-associated ligand for binding to CFTR to regulate CFTR-mediated fluid transport, J Biol Chem, 288, 12325, 10.1074/jbc.M112.432724 Geibel, 2006, Calcium-sensing receptor abrogates secretagogue-induced increases in intestinal net fluid secretion by enhancing cyclic nucleotide destruction, Proc Natl Acad Sci U S A, 103, 9390, 10.1073/pnas.0602996103 Cheng, 2012, Calcium-sensing receptor inhibits secretagogue-induced electrolyte secretion by intestine via the enteric nervous system, Am J Physiol Gastrointest Liver Physiol, 303, G60, 10.1152/ajpgi.00425.2011 Thiagarajah, 2004, Prevention of toxin-induced intestinal ion and fluid secretion by a small-molecule CFTR inhibitor, Gastroenterology, 126, 511, 10.1053/j.gastro.2003.11.005 Berschneider, 1988, Altered intestinal chloride transport in cystic fibrosis, FASEB J, 2, 2625, 10.1096/fasebj.2.10.2838365 Rufo, 2004, Diarrhea-associated HIV-1 APIs potentiate muscarinic activation of Cl− secretion by T84 cells via prolongation of cytosolic Ca2+ signaling, Am J Physiol Cell Physiol, 286, C998, 10.1152/ajpcell.00357.2003 Ma, 2002, Thiazolidinone CFTR inhibitor identified by high-throughput screening blocks cholera toxin-induced intestinal fluid secretion, J Clin Invest, 110, 1651, 10.1172/JCI0216112 Caci, 2008, Evidence for direct CFTR inhibition by CFTRinh-172 based on arginine 347 mutagenesis, Biochem J, 413, 135, 10.1042/BJ20080029 Sonawane, 2005, In vivo pharmacology and antidiarrheal efficacy of a thiazolidinone CFTR inhibitor in rodents, J Pharm Sci, 94, 134, 10.1002/jps.20228 Sonawane, 2008, Thiazolidinone CFTR inhibitors with improved water solubility identified by structure–activity analysis, Bioorg Med Chem, 16, 8187, 10.1016/j.bmc.2008.07.044 Tradtrantip, 2009, Nanomolar potency pyrimido-pyrrolo-quinoxalinedione CFTR inhibitor reduces cyst size in a polycystic kidney disease model, J Med Chem, 52, 6447, 10.1021/jm9009873 Snyder, 2013, Absolute configuration and biological properties of enantiometers of CFTR inhibitor BPO-27, ACS Med Chem Lett, 4, 456, 10.1021/ml400069k Snyder, 2011, Potent, metabolically stable benzopyrimido-pyrrolo-oxazine-dione (BPO) CFTR inhibitors for polycystic kidney disease, J Med Chem, 54, 5468, 10.1021/jm200505e Muanprasat, 2004, Discovery of glycine hydrazide pore-occluding CFTR inhibitors: mechanism, structure–activity analysis, and in vivo efficacy, J Gen Physiol, 124, 125, 10.1085/jgp.200409059 Sonawane, 2008, Nanomolar CFTR inhibition by pore-occluding divalent polyethylene glycol-malonic acid hydrazides, Chem Biol, 15, 718, 10.1016/j.chembiol.2008.05.015 Norimatsu, 2012, Locating a plausible binding site for an open channel blocker, GlyH-101, in the pore of the cystic fibrosis transmembrane conductance regulator, Mol Pharmacol, 82, 1042, 10.1124/mol.112.080267 de Hostos, 2011, Developing novel antisecretory drugs to treat infectious diarrhea, Future Med Chem, 3, 1317, 10.4155/fmc.11.87 Sonawane, 2007, Lectin conjugates as potent, nonabsorbable CFTR inhibitors for reducing intestinal fluid secretion in cholera, Gastroenterology, 132, 1234, 10.1053/j.gastro.2007.02.018 De La Fuente, 2008, Small-molecule screen identifies inhibitors of a human intestinal calcium-activated chloride channel, Mol Pharmacol, 73, 758, 10.1124/mol.107.043208 Namkung, 2011, TMEM16A inhibitors reveal TMEM16A as a minor component of CaCC conductance in airway and intestinal epithelial cells, J Biol Chem, 286, 2365, 10.1074/jbc.M110.175109 Namkung, 2011, Small-molecule activators of TMEM16A, a calcium-activated chloride channel, stimulate epithelial chloride secretion and intestinal contraction, FASEB J, 25, 4048, 10.1096/fj.11-191627 Jin, 2013, Convective washout reduces the antidiarrheal efficacy of enterocyte surface-targeted antisecretory drugs, J Gen Physiol, 141, 261, 10.1085/jgp.201210885 Yeo, 2013, Crofelemer, a novel antisecretory agent approved for the treatment of HIV-associated diarrhea, Drugs Today (Barc), 49, 239, 10.1358/dot.2013.49.4.1947253 Tradtrantip, 2010, Crofelemer, an antidiarrheal proanthocyanidin oligomer extracted from Croton lechleri, targets two distinct intestinal chloride channels, Mol Pharmacol, 77, 69, 10.1124/mol.109.061051 Namkung, 2010, Inhibition of Ca2+-activated Cl− channels by gallotannins as a possible molecular basis of health benefits of green tea and red wine, FASEB J, 24, 4178, 10.1096/fj.10-160648